General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ran ZH et al. – The authors results confirmed that monoclonal antibody targeted to EGFR could be effective in increasing response rates and could be a key therapeutic agent in the optimal treatment of mCRC, despite a moderate increase in grades 3–4 adverse events.

Related Articles

Visceral Fat Volume and the Prevalence of Colorectal Adenoma
American Journal of Epidemiology, 11/19/09    Relevance Score: 68%

P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09    Relevance Score: 68%

Surgical management of colorectal liver metastases
Community Oncology, 10/09/09    Relevance Score: 68%

The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09    Relevance Score: 67%

Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09    Relevance Score: 67%

Today in Colorectal Cancer/Polyps...keeping you current

Distinct features of colorectal cancer in children and adolescents
Cancer, 12/15/09

Position Statement: Nonanesthesiologist Administration of Propofol for GI Endoscopy
Gastroenterology, 12/15/09

Colorectal cancer: incidence and trend in Brunei Darussalam
Singapore Medical Journal, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address